Skip to main content
. 2023 Feb;51(2):257–267. doi: 10.1124/dmd.122.001048

Fig. 3.

Fig. 3.

Optimized S-warfarin (A) and R-warfarin (B) PBPK model with TMDD mechanism predictions overlaid with observations in subjects with various CYP2C9 genotypes when warfarin is administered alone. Dots represent observations. Red lines represent median predictions.